Dana Investment Advisors, Inc. Halozyme Therapeutics, Inc. Transaction History

Dana Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$36.46 - $44.03 $351,474 - $424,449	-9,640 Reduced 59.68%	6,513 $248,000
Q2 2023 Aug 15, 2023	SELL	$30.28 - $38.74 $3.9 Million - $4.99 Million	-128,915 Reduced 88.87%	16,153 $582,000
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $1.81 Million - $3.07 Million	55,036 Added 61.13%	145,068 $5.54 Million
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $3.61 Million - $5.35 Million	90,032 New	90,032 $5.12 Million

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.